Weaknesses : Limited Direct Evidence for T1D : While the use of GLP-1 receptor agonists in T2D is well supported, there is a paucity of large-scale, long-term clinical trials examining their use as adjuncts to insulin in T1D, particularly for those with overweight or obesity
Combination therapies to watch Some patients combine semaglutide with other compounds
It underscores the importance of collaboration between patients, healthcare providers, pharmacies, shipping companies, and regulatory authorities
This means that seven days after an injection, about half of the medication remains in your system
She's lost 80 pounds, first on Mounjaro, now on compounded semaglutide, to get to 189 pounds
These symptoms may indicate that your current dose is too high for your system, requiring a step-back to a lower dose or an extended plateau before advancing again